SRI Logo
Therapeutic Areas
Plus buttonPreclinical Development
 -Drug Substance Preparation
 -Formulation Studies
 -Safety Toxicology
 -PK/ADME Studies
 -Analytical Chemistry
 -Quality Assurance
 -Clinical Trial Materials Manufacturing
 IND Preparation & Submission
 -FDA Pre-IND Mtg.
 -IND Preparation
 -Regulatory Submission
Clinical Laboratory Services
Clinical Laboratory Services
Site Map
Out-Licensing Opportunities
NIMH Toxicology Program
Grant Teaming
Center for Advanced Drug Research (CADRE)
Publications
Conferences and Events
Request Brochure
Government Clients
 Biosciences Division
Spacer

Spacer
         
  SRI Logo

IND Preparation

  • Meeting requirements of 21 CFR 312
  • Coordination of receipt, editing, review and revision of IND documents
  • Assembling, indexing, copying and distributing documents
  • Follow-up to FDA—review comments and preparation of a response
  • Prepare amendments and supplemental submissions

 

 

 

 

 

 

 

Contact Us
     Last Updated Jul 17, 2008

 

About Us  Vertical divider  R&D Divisions  Divider  Careers  Divider  Newsroom  Divider  Contact Us
©2008 SRI International 333 Ravenswood Avenue, Menlo Park, CA 94025-3493
SRI International is an independent, nonprofit corporation. Privacy policy